Detalhe da pesquisa
1.
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
Br J Haematol
; 204(1): 171-176, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710381
2.
Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
Haematologica
; 109(6): 1779-1791, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299584
3.
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546692
4.
Determinants of outcomes and advances in CD19-directed chimeric antigen receptor therapy for B-cell acute lymphoblastic leukemia.
Eur J Haematol
; 112(1): 51-63, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105391
5.
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Am J Hematol
; 99(2): 193-202, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071734
6.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Am J Hematol
; 99(2): E63-E66, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100217
7.
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
Br J Haematol
; 202(2): 279-283, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144345
8.
Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms.
Haematologica
; 108(11): 3033-3043, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199125
9.
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression.
Am J Hematol
; 98(3): 472-480, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625066
10.
Membranous Nephropathy With Extensive Tubular Basement Membrane Deposits Following Allogeneic Hematopoietic Cell Transplant: A Report of 5 Cases.
Am J Kidney Dis
; 79(6): 904-908, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508832
11.
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.
Am J Hematol
; 97(8): 1013-1022, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560061
12.
Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity.
Am J Transplant
; 21(2): 883-888, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32805087
13.
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
Ann Hematol
; 99(3): 513-518, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974678
14.
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
Am J Hematol
; 95(12): 1511-1521, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833294
15.
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
Am J Hematol
; 95(10): 1170-1179, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618000
16.
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy.
Ann Hematol
; 98(2): 331-337, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334068
17.
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy.
Haematologica
; 108(11): 3170-3174, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861409
18.
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
Ann Hematol
; 102(1): 211-212, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331566
19.
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
Am J Hematol
; 98(2): E28-E31, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403135
20.
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
Ann Hematol
; 101(12): 2785-2787, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184685